HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J Appl Physiol 98: 2191-2196, 2005. First published March 17, 2005; doi:10.1152/japplphysiol.00216.2005
8750-7587/05 $8.00

This Article Free upon publication Full Text Free Full Text (PDF) Free All Versions of this Article: 98/6/2191    most recent 00216.2005v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Coyle, E. F. Search for Related Content PubMed PubMed Citation Articles by Coyle, E. F.

Improved muscular efficiency displayed as Tour de France champion matures

Human Performance Laboratory, Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, Texas

Submitted 22 February 2005 ; accepted in final form 10 March 2005

This case describes the physiological maturation from ages 21 to 28 yr of the bicyclist who has now become the six-time consecutive Grand Champion of the Tour de France, at ages 27–32 yr. Maximal oxygen uptake (O_{2 max}) in the trained state remained at 6 l/min, lean body weight remained at 70 kg, and maximal heart rate declined from 207 to 200 beats/min. Blood lactate threshold was typical of competitive cyclists in that it occurred at 76–85% O_{2 max}, yet maximal blood lactate concentration was remarkably low in the trained state. It appears that an 8% improvement in muscular efficiency and thus power production when cycling at a given oxygen uptake (O₂) is the characteristic that improved most as this athlete matured from ages 21 to 28 yr. It is noteworthy that at age 25 yr, this champion developed advanced cancer, requiring surgeries and chemotherapy. During the months leading up to each of his Tour de France victories, he reduced body weight and body fat by 4–7 kg (i.e., 7%). Therefore, over the 7-yr period, an improvement in muscular efficiency and reduced body fat contributed equally to a remarkable 18% improvement in his steady-state power per kilogram body weight when cycling at a given O₂ (e.g., 5 l/min). It is hypothesized that the improved muscular efficiency probably reflects changes in muscle myosin type stimulated from years of training intensely for 3–6 h on most days.

maximum oxygen uptake; blood lactate concentration

This article has been cited by other articles:

				C. J. Gore, M. J. Ashenden, K. Sharpe, and D. T. Martin Delta efficiency calculation in Tour de France champion is wrong J Appl Physiol, September 1, 2008; 105(3): 1020 - 1020. [Full Text] [PDF]

				E. F. Coyle Reply to Gore, Ashenden, Sharpe, and Martin J Appl Physiol, September 1, 2008; 105(3): 1021 - 1021. [Full Text] [PDF]

				A. Lucia, J. Olivan, J. Bravo, M. Gonzalez-Freire, and C. Foster The key to top-level endurance running performance: a unique example Br. J. Sports Med., March 1, 2008; 42(3): 172 - 174. [Full Text] [PDF]

				M. J. Joyner and E. F. Coyle Endurance exercise performance: the physiology of champions J. Physiol., January 1, 2008; 586(1): 35 - 44. [Abstract] [Full Text] [PDF]

				P. M. Garcia-Roves, J. Huss, and J. O. Holloszy Role of calcineurin in exercise-induced mitochondrial biogenesis Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1172 - E1179. [Abstract] [Full Text] [PDF]

				M. Mogensen, M. Bagger, P. K. Pedersen, M. Fernstrom, and K. Sahlin Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency J. Physiol., March 15, 2006; 571(3): 669 - 681. [Abstract] [Full Text] [PDF]

				J. S. Woo, C. Derleth, J. R. Stratton, and W. C. Levy The Influence of Age, Gender, and Training on Exercise Efficiency J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1049 - 1057. [Abstract] [Full Text] [PDF]

				T. D. Noakes, P. E. di Prampero, C. Capelli, T. Zaobornyj, L. B Valdez, A. Boveris, M. Ashenden, T. W. Secomb, S. Dufour, E. Ponsot, et al. Comments on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume" J Appl Physiol, December 1, 2005; 99(6): 2453 - 2462. [Full Text] [PDF]

				D. T. Martin, M. J. Quod, C. J. Gore, and E. F. Coyle Has Armstrong's cycle efficiency improved? J Appl Physiol, October 1, 2005; 99(4): 1628 - 1629. [Abstract] [Full Text] [PDF]

				Y. O. Schumacher, S. Vogt, K. Roecker, A. Schmid, and E. F. Coyle Scientific considerations for physiological evaluations of elite athletes J Appl Physiol, October 1, 2005; 99(4): 1630 - 1631. [Abstract] [Full Text] [PDF]

				Highlights from the Literature Physiology, October 1, 2005; 20(5): 287 - 291. [Full Text] [PDF]